Doxorubicin Hydrochloride liposome

Product NDC
59676-966
11-digit product format
596760966
Labeler code
59676
Product ID
59676-966_2100bf6a-67f3-11e9-9dee-13020199106d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
doxorubicin hydrochloride
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Labeler
Janssen Products, LP
Application
NDA050718
Marketing category
NDA
Marketing start
2017-06-26
Marketing end
2020-10-31
Substance
DOXORUBICIN HYDROCHLORIDE
Active strength
2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59676-966-01ML - Milliliter59676-96662d9af4f-4e39-4766-8f2d-126ae94fda1d12017-08-11
59676-966-02ML - Milliliter59676-9664d84e7b8-5782-434f-ae45-78c1bbc1456c12017-09-11